Show simple item record

dc.contributor.authorLittle, Karis
dc.contributor.authorLlorián-Salvador, María
dc.contributor.authorScullion, Sarah
dc.contributor.authorHernández, Cristina
dc.contributor.authorSimó-Servat, Olga
dc.contributor.authorMarco Delgado, Ángel José del 
dc.contributor.authorBosma, Esmeralda
dc.contributor.authorVargas Soria, María 
dc.contributor.authorCarranza Naval, María José 
dc.contributor.authorVan Bergen, Tine
dc.contributor.authorGalbiati, Silvia
dc.contributor.authorViganò, Ilaria
dc.contributor.authorMusi, Clara Alice
dc.contributor.authorSchlingemann, Reiner
dc.contributor.authorFeyen, Jean
dc.contributor.authorBorsello, Tiziana
dc.contributor.authorZerbini, Gianpaolo
dc.contributor.authorKlaassen, Ingeborg
dc.contributor.authorGarcía Alloza, Mónica 
dc.contributor.authorSimó, Rafael
dc.contributor.authorStitt, Alan W.
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2026-02-20T13:35:39Z
dc.date.available2026-02-20T13:35:39Z
dc.date.issued2022
dc.identifier.issn1043-2760
dc.identifier.urihttp://hdl.handle.net/10498/38787
dc.description.abstractType 2 diabetes (T2D) is associated with multiple comorbidities, including diabetic retinopathy (DR) and cognitive decline, and T2D patients have a significantly higher risk of developing Alzheimer's disease (AD). Both DR and AD are characterized by a number of pathological mechanisms that coalesce around the neurovascular unit, including neuroinflammation and degeneration, vascular degeneration, and glial activation. Chronic hyperglycemia and insulin resistance also play a significant role, leading to activation of pathological mechanisms such as increased oxidative stress and the accumulation of advanced glycation end-products (AGEs). Understanding these common pathways and the degree to which they occur simultaneously in the brain and retina during diabetes will provide avenues to identify T2D patients at risk of cognitive decline.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.sourceTrends Endocrinol Metab. 2022 Jan;33(1):50-71es_ES
dc.subjectAlzheimer’s diseasees_ES
dc.subjectCognitive declinees_ES
dc.subjectDiabeteses_ES
dc.subjectNeurovascular unites_ES
dc.titleCommon pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive declinees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsclosed accesses_ES
dc.identifier.doi10.1016/j.tem.2021.10.008
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record